Whole‐genome Sequencing Identifies EN1 As a Determinant of Bone Density and Fracture
Hou‐Feng Zheng,Vincenzo Forgetta,Yi‐Hsiang Hsu,Karol Estrada,Alberto Rosello‐Diez,Paul J. Leo,Chitra L. Dahia,Kyung Hyun Park‐Min,Jonathan H. Tobias,Charles Kooperberg,Aaron Kleinman,Unnur Styrkarsdottir,Ching‐Ti Liu,Charlotta Uggla,Daniel S. Evans,Carrie M. Nielson,Klaudia Walter,Ulrika Pettersson‐Kymmer,Shane McCarthy,Joel Eriksson,Tony Kwan,Mila Jhamai,Katerina Trajanoska,Yasin Memari,Josine Min,Jie Huang,Petr Danecek,Beth Wilmot,Rui Li,Wen‐Chi Chou,Lauren E. Mokry,Alireza Moayyeri,Melina Claussnitzer,Chia‐Ho Cheng,Warren Cheung,Carolina Medina‐Gómez,Bing Ge,Shu‐Huang Chen,Kwangbom Choi,Ling Oei,James Fraser,Robert Kraaij,Matthew A. Hibbs,Celia L. Gregson,Denis Paquette,Albert Hofman,Carl Wibom,Gregory J. Tranah,Mhairi Marshall,Brooke B. Gardiner,Katie Cremin,Paul Auer,Li Hsu,Sue Ring,Joyce Y. Tung,Gudmar Thorleifsson,Anke W. Enneman,Natasja M. van Schoor,Lisette C. P. G. M. de Groot,Nathalie van der Velde,Beatrice Melin,John P. Kemp,Claus Christiansen,Adrian Sayers,Yanhua Zhou,Sophie Calderari,Jeroen van Rooij,Chris Carlson,Ulrike Peters,Soizik Berlivet,Josée Dostie,Andre G. Uitterlinden,Stephen R. Williams,Charles Farber,Daniel Grinberg,Andrea Z. LaCroix,Jeff Haessler,Daniel I. Chasman,Franco Giulianini,Lynda M. Rose,Paul M. Ridker,John A. Eisman,Tuan V. Nguyen,Jacqueline R. Center,Xavier Nogues,Natalia Garcia‐Giralt,Lenore L. Launer,Vilmunder Gudnason,Dan Mellström,Liesbeth Vandenput,Najaf Amin,Cornelia M. van Duijn,Magnus K. Karlsson,Östen Ljunggren,Olle Svensson,Göran Hallmans,François Rousseau,Sylvie Giroux,Johanne Bussière,Pascal P. Arp,Fjorda Koromani,Richard L. Prince,Joshua R. Lewis,Bente L. Langdahl,A. Pernille Hermann,Jens‐Erik B. Jensen,Stephen Kaptoge,Kay‐Tee Khaw,Jonathan Reeve,Melissa M. Formosa,Angela Xuereb‐Anastasi,Kristina Åkesson,Fiona E. McGuigan,Gaurav Garg,Jose M. Olmos,Maria T. Zarrabeitia,Jose A. Riancho,Stuart H. Ralston,Nerea Alonso,Xi Jiang,David Goltzman,Tomi Pastinen,Elin Grundberg,Dominique Gauguier,Eric S. Orwoll,David Karasik,George Davey‐Smith,Albert V. Smith,Kristin Siggeirsdottir,Tamara B. Harris,M. Carola Zillikens,Joyce B. J. van Meurs,Unnur Thorsteinsdottir,Matthew T. Maurano,Nicholas J. Timpson,Nicole Soranzo,Richard Durbin,Scott G. Wilson,Evangelia E. Ntzani,Matthew A. Brown,Kari Stefansson,David A. Hinds,Tim Spector,L. Adrienne Cupples,Claes Ohlsson,Celia M. T. Greenwood,Rebecca D. Jackson,David W. Rowe,Cynthia A. Loomis,David M. Evans,Cheryl L. Ackert‐Bicknell,Alexandra L. Joyner,Emma L. Duncan,Douglas P. Kiel,Fernando Rivadeneira,J. Brent Richards
DOI: https://doi.org/10.1038/nature14878
IF: 64.8
2015-01-01
Nature
Abstract:Human population genomic studies, including whole‐genome sequencing, were undertaken to identify determinants of bone mineral density (BMD), a major predictor of osteoporotic fractures. Non‐coding variants with large effects on BMD and fractures were identified near the EN1 locus and mouse studies confirmed this gene has an important role in skeletal biology. Bone mineral density (BMD) is heritable and is a major predictor of osteoporotic fractures. Using whole-genome sequencing from the UK10K consortium, whole exome sequencing and deep imputation of genotyped samples using a combined UK10K/1000 Genomes reference panel, this collaborative study identifies novel non-coding genetic variants with large effects on bone density in individuals of European ancestry. Notable findings include low-frequency non-coding variants near the EN1 locus — and mouse studies confirm that this gene has a role in determining bone mass. In addition, the authors observed an excess of association signals arising from deleterious coding and conserved non-coding variants. Collectively, this work suggests that low-frequency non-coding variants have large effects on BMD and fracture in the general population. The extent to which low‐frequency (minor allele frequency (MAF) between 1–5%) and rare (MAF ≤ 1%) variants contribute to complex traits and disease in the general population is mainly unknown. Bone mineral density (BMD) is highly heritable, a major predictor of osteoporotic fractures, and has been previously associated with common genetic variants1,2,3,4,5,6,7,8, as well as rare, population‐specific, coding variants9. Here we identify novel non‐coding genetic variants with large effects on BMD (ntotal = 53,236) and fracture (ntotal = 508,253) in individuals of European ancestry from the general population. Associations for BMD were derived from whole‐genome sequencing (n = 2,882 from UK10K (ref. 10); a population‐based genome sequencing consortium), whole‐exome sequencing (n = 3,549), deep imputation of genotyped samples using a combined UK10K/1000 Genomes reference panel (n = 26,534), and de novo replication genotyping (n = 20,271). We identified a low‐frequency non‐coding variant near a novel locus, EN1, with an effect size fourfold larger than the mean of previously reported common variants for lumbar spine BMD8 (rs11692564(T), MAF = 1.6%, replication effect size = +0.20 s.d., Pmeta = 2 × 10−14), which was also associated with a decreased risk of fracture (odds ratio = 0.85; P = 2 × 10−11; ncases = 98,742 and ncontrols = 409,511). Using an En1cre/flox mouse model, we observed that conditional loss of En1 results in low bone mass, probably as a consequence of high bone turnover. We also identified a novel low‐frequency non‐coding variant with large effects on BMD near WNT16 (rs148771817(T), MAF = 1.2%, replication effect size = +0.41 s.d., Pmeta = 1 × 10−11). In general, there was an excess of association signals arising from deleterious coding and conserved non‐coding variants. These findings provide evidence that low‐frequency non‐coding variants have large effects on BMD and fracture, thereby providing rationale for whole‐genome sequencing and improved imputation reference panels to study the genetic architecture of complex traits and disease in the general population.